JPWO2020056204A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020056204A5 JPWO2020056204A5 JP2021513947A JP2021513947A JPWO2020056204A5 JP WO2020056204 A5 JPWO2020056204 A5 JP WO2020056204A5 JP 2021513947 A JP2021513947 A JP 2021513947A JP 2021513947 A JP2021513947 A JP 2021513947A JP WO2020056204 A5 JPWO2020056204 A5 JP WO2020056204A5
- Authority
- JP
- Japan
- Prior art keywords
- region
- masseter
- botulinum toxin
- lower facial
- facial width
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010043024 Botulinum Toxins Proteins 0.000 claims 2
- 210000001352 Masseter Muscle Anatomy 0.000 claims 2
- 229940053031 botulinum toxin Drugs 0.000 claims 2
- 230000001815 facial Effects 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862731064P | 2018-09-13 | 2018-09-13 | |
| US62/731,064 | 2018-09-13 | ||
| PCT/US2019/050910 WO2020056204A1 (en) | 2018-09-13 | 2019-09-12 | Methods for treatment of masseter muscle hypertrophy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022500417A JP2022500417A (ja) | 2022-01-04 |
| JPWO2020056204A5 true JPWO2020056204A5 (de) | 2022-09-21 |
Family
ID=68069888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021513947A Pending JP2022500417A (ja) | 2018-09-13 | 2019-09-12 | 咬筋肥大症の治療方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20200085923A1 (de) |
| EP (1) | EP3849585A1 (de) |
| JP (1) | JP2022500417A (de) |
| KR (1) | KR20210057106A (de) |
| CN (1) | CN112955166A (de) |
| AU (1) | AU2019337656A1 (de) |
| BR (1) | BR112021004776A2 (de) |
| CA (1) | CA3112227A1 (de) |
| MX (1) | MX2021002993A (de) |
| TW (1) | TWI835858B (de) |
| WO (1) | WO2020056204A1 (de) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6306423B1 (en) | 2000-06-02 | 2001-10-23 | Allergan Sales, Inc. | Neurotoxin implant |
| US6423319B1 (en) * | 2000-10-04 | 2002-07-23 | Allergan Sales, Inc. | Methods for treating muscle injuries |
| MXPA05003936A (es) * | 2002-10-15 | 2005-06-17 | Allergan Inc | Terapias y procedimientos odontologicos con toxina botulinica. |
| US20060057165A1 (en) * | 2004-09-10 | 2006-03-16 | Dimitrios Dimitrakoudis | Clostridium botulinum toxin formulation and method for reducing weight |
| WO2006073410A1 (en) * | 2005-01-03 | 2006-07-13 | Botulinum Toxin Research Associates, Inc. | Compositions, methods and devices for preparing less painful botulinum toxin formulations |
| WO2009139739A1 (en) * | 2006-02-14 | 2009-11-19 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Compositions comprising a combination of botulinum toxin a and botulinum toxin b for treating conditions characterized by unwanted or excessive presynaptic neuronal activity or secretion |
| US20080021437A1 (en) * | 2006-04-27 | 2008-01-24 | Boyd James P | Enhancement of the efficacy of a clenching reduction device by augmenting with botulinum toxin type A |
| RU2535115C1 (ru) * | 2013-05-15 | 2014-12-10 | Бости Трейдинг Лтд | Фармацевтический состав, содержащий нейротоксин ботулина |
| US20180311333A1 (en) * | 2015-10-29 | 2018-11-01 | Revance Therapeutics, Inc. | Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic Effect |
-
2019
- 2019-09-12 BR BR112021004776A patent/BR112021004776A2/pt unknown
- 2019-09-12 AU AU2019337656A patent/AU2019337656A1/en active Pending
- 2019-09-12 KR KR1020217010431A patent/KR20210057106A/ko not_active Application Discontinuation
- 2019-09-12 MX MX2021002993A patent/MX2021002993A/es unknown
- 2019-09-12 WO PCT/US2019/050910 patent/WO2020056204A1/en unknown
- 2019-09-12 JP JP2021513947A patent/JP2022500417A/ja active Pending
- 2019-09-12 CA CA3112227A patent/CA3112227A1/en active Pending
- 2019-09-12 CN CN201980069678.6A patent/CN112955166A/zh active Pending
- 2019-09-12 EP EP19778736.9A patent/EP3849585A1/de active Pending
- 2019-09-13 US US16/570,232 patent/US20200085923A1/en not_active Abandoned
- 2019-09-16 TW TW108133293A patent/TWI835858B/zh active
-
2022
- 2022-05-30 US US17/804,575 patent/US20230080740A1/en active Pending
- 2022-05-30 US US17/804,577 patent/US20230083250A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ700623A (en) | Botulinum toxin dosage regimen for chronic migraine prophylaxis | |
| ATE531387T1 (de) | Nahtlinien-verabreichungstechnik mit botulinustoxinen | |
| JP2009517473A5 (de) | ||
| JP2013523753A5 (de) | ||
| WO2005082339A3 (en) | Medicaments and methods for treating headache | |
| JP2008505857A5 (de) | ||
| JP2007527914A5 (de) | ||
| WO2008033792A3 (en) | Repetitive transcranial magnetic stimulation for movement disorders | |
| CN107485536A (zh) | 一种按摩床 | |
| WO2007087154A3 (en) | Methods for enhancing therapeutic effects of a neurotoxin | |
| EP2043637A4 (de) | Verfahren und medikamente zur verabreichung von ibuprofen | |
| PH12020551159A1 (en) | Methods of treating subjects having diabetes with chronic kidney disease | |
| FI2683245T4 (fi) | Menetelmiä ja koostumuksia masennuksen hoitamiseen syklobentsapriiniä käyttämällä | |
| JPWO2020056204A5 (de) | ||
| MX2022013923A (es) | Metodos para tratar la enfermedad de crohn con el anticuerpo especifico anti-il23. | |
| CN104382725A (zh) | 一种鼠标手治疗仪 | |
| JP2016501208A5 (de) | ||
| RU2005135189A (ru) | Способ повышения продуктивности кур-несушек | |
| RU2005139047A (ru) | Способ лечения острых посттравматических цефалгий | |
| RU2006102226A (ru) | Способ уменьшения побочных эффектов при лечении туберкулеза | |
| WO2006078588A3 (en) | Improved methods for treating headache | |
| MX2022002947A (es) | Avocatina b para el tratamiento de enfermedades y afecciones. | |
| JP2021192835A5 (de) | ||
| MX2024005860A (es) | Métodos para tratar la enfermedad de crohn con el anticuerpo específico anti-il23. | |
| Broadbent et al. | INTERMITTENT COMPARED TO GRADED EXERCISE FOR INDIVIDUALS WITH CHRONIC FATIGUE SYNDROME |